Search

everythinglearnresearchcommunity

for

Search:↓

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

Most tinea capitis cases in southern Taiwan were in adult women, mainly caused by Trichophyton violaceum.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Menopause affects hair and skin; more research needed for treatment.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.